With ten million individuals afflicted each year, no one is entirely immune to cancer and its devastating effects on individuals and families. But recent advances in the development of cancer vaccines—either as therapeutic agents or preventative measures—are hopeful indicators of progress in this field.

This symposium brings together world-renowned researchers and clinicians to shed light on these recent steps forward in cancer studies. Its primary goal is to contribute to the advancement of new immunotherapeutic and preventive approaches for future cancer vaccines.

Scientific Organizing Committee

• Jacques Banchereau, Baylor University
• Olja Finn, University of Pittsburgh
  
• Kenichiro Hasumi, The Hasumi International Research Foundation
• Ralph Steinman, The Rockefeller University

Presented by

Supported by